Screening optimal target populations with symptomatic bradyarrhythmia for pharmacotherapy: a discriminant analysis pilot study.
Our model based on the clinical features of patients with bradyarrhythmia. Should be useful aid for predicting pharmacotherapy response and could screen the optimal pharmacotherapy target.
Authors
- Baochen Zhu (ORCID: https://orcid.org/0000-0002-0536-6429)
- Xujie Wang
- Wantong Zhang (ORCID: https://orcid.org/0000-0002-0489-0202)
- Weiliang Weng (ORCID: https://orcid.org/0000-0002-5543-192X)
- Danhui Yi
- Qiuyan Li (ORCID: https://orcid.org/0000-0002-8183-9945)
- Shuai Shi
- Fang Lü (ORCID: https://orcid.org/0000-0001-6112-7214)
- Yang Qiaoning
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
- Xiyuan Hospital (CN)
- Renmin University of China (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-02-01
- DOI
- https://doi.org/10.19852/j.cnki.jtcm.2025.01.015
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- State Administration of Traditional Chinese Medicine of the People's Republic of China